Unknown

Dataset Information

0

Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation

ABSTRACT:

SUBMITTER: Koster E 

PROVIDER: S-EPMC10966113 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation.
| S-EPMC10805111 | biostudies-literature
Unknown Durable remission of renal cell carcinoma in conjuncture with graft versus host disease following allogeneic stem cell transplantation and donor lymphocyte infusion: rule or exception?
| S-EPMC3893183 | biostudies-literature
Unknown HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation.
| S-EPMC11822263 | biostudies-literature
Unknown Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation.
| S-EPMC12378914 | biostudies-literature
Unknown Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients.
| S-EPMC10102042 | biostudies-literature
Unknown Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation.
| S-EPMC7509859 | biostudies-literature
Unknown Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation.
| S-EPMC10601734 | biostudies-literature
Unknown Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation.
| S-EPMC7571859 | biostudies-literature
Unknown Impact of Donor Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
| S-EPMC10695696 | biostudies-literature
Unknown PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation.
| S-EPMC11881745 | biostudies-literature